Tribe Public Archives

Promotional graphic for a Tribe Public CEO dinner event featuring Eupraxia Pharmaceuticals (NASDAQ: EPRX), James Helliwell, M.D., and the company’s 52-week EP-104GI clinical update for eosinophilic esophagitis. The image illustrates localized treatment at week zero, durable symptom control through week 52, and a stylized upward EPRX market graphic.

Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )

by John F. Heerdink, Jr. September 30, 2026 389Views 0Likes

Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has added a potentially important chapter to its eosinophilic esophagitis, or EoE, story: a single administration of its investigational localized therapy, EP-104GI, continued to show clinical-remission signals at 52 weeks in the highest-dose cohorts of the…

Promotional graphic for Tribe Public’s CEO presentation and Q&A webinar, “A New Approach to Advanced Parkinson’s Disease: Exploring SER-252’s Clinical Progress,” featuring Serina Therapeutics CEO Steven Ledger; September 24, 2026, at 8:30 a.m. PT / 11:30 a.m. ET.

Serina Therapeutics Puts Advanced Parkinson’s Disease in the Spotlight – Thursday, September 24

by John F. Heerdink, Jr. September 23, 2026 181Views 0Likes

Parkinson’s disease is one of medicine’s most stubborn commercial and scientific frontiers, and Serina Therapeutics, Inc. (NYSE American: SER) is positioning its lead program, SER-252, squarely in the middle of that opportunity. The clinical-stage biotechnology company has opened registration for a Tribe Public CEO…

Comic-book-style Wall Street illustration featuring a charging bull superhero, symbols of insider conviction and high-speed OLED technology, virtual-care clinicians, and a scientist representing Parkinson’s disease research, beneath the headline “Wall Street’s Bullish New Menu.”

Wall Street’s Bullish New Menu: Insider Conviction, OLED Speed, Virtual Care and a Parkinson’s Catalyst -( $AMWL $GME $LPL $PFE $SER $XBI )

by John F. Heerdink, Jr. September 22, 2026 267Views 0Likes

The market’s most compelling bullish narratives rarely arrive wearing the same uniform. This week, they span a CEO buying millions of dollars of his own stock, an OLED display running at a downright impolite 720Hz, a telehealth company pursuing large institutional accounts,…

Tribe Public CEO Presentation and Q&A webinar graphic featuring Serina Therapeutics CEO Steven Ledger, NYSE: SER, promoting “A New Approach to Advanced Parkinson’s Disease: Exploring SER-252’s Clinical Progress,” with a global network map, molecular imagery, and Register Now call to action.

Serina Therapeutics Brings a Fresh Dose of Momentum to Advanced Parkinson’s Care -( $SER $PFE $XBI )

by John F. Heerdink, Jr. September 21, 2026 349Views 0Likes

Serina Therapeutics, Inc. (NYSE American: SER) is approaching a consequential clinical milestone with SER-252, its long-acting POZ-apomorphine candidate for advanced Parkinson’s disease, now advancing into Cohort 2 of a registrational Phase 1b study. For many, the appeal is not simply that Serina is pursuing…

Stylized world map showing the United States highlighted at the center, with glowing pink connection lines linking Los Angeles, Chicago, New York, Washington, D.C., London, Berlin, Beijing, Tokyo and Sydney—illustrating global investor engagement, corporate access and virtual CEO communication.

The New Premium Asset: Attention That Shows Up

by John F. Heerdink, Jr. September 21, 2026 220Views 0Likes

In an era when nearly every company can publish a deck, record a webcast and summon an algorithmic audience, the scarce asset is becoming more human: a room, or a virtual room, filled with people who actually care enough to listen, ask…

Knightscope’s Next Act: Why an Autonomous Security Force Could Turn a Fragmented Industry Into a Recurring-Revenue Opportunity -( $F $KSCP $LKQ $PLTR )

by John F. Heerdink, Jr. September 11, 2026 389Views 0Likes

Knightscope (NASDAQ: KSCP) is pursuing a bigger prize than selling robots: it is assembling an integrated, technology-enabled security service designed to combine autonomous machines, AI software, remote monitoring and licensed human agents under one accountable operating model. There is no shortage of…

Investor-themed graphic showing Tribe Public and ACOG logos above a rising green-and-gold stock chart, dollar signs, and the Zunveyl (benzgalantamine) 5 mg, 10 mg, and 15 mg branding against a modern city backdrop.

Alpha Cognition’s Commercial Alzheimer’s Story Is Getting Harder to Ignore -( $ACOG )

by John F. Heerdink, Jr. September 6, 2026 316Views 0Likes

Alpha Cognition Inc. (NASDAQ: ACOG) has moved meaningfully beyond the familiar small-cap biotech ritual of promising future potential. Since CEO Michael McFadden’s January 15, 2026 Tribe Public luncheon presentation during the J.P. Morgan Healthcare Conference week in San Francisco, the company has paired…

Promotional graphic for the Tribe Public CEO Webinar featuring Knightscope Founder, Chairman and CEO William Santana Li, an autonomous security robot in a futuristic city setting, and webinar details for Thursday, September 10, 2026, at 8:30 a.m. PT / 11:30 a.m. ET.

Knightscope (NASDAQ: $KSCP) to Spotlight Autonomous Security Force Built With AI, Robotics and Humans at Tribe Public CEO Webinar – Sept. 10

by John F. Heerdink, Jr. September 5, 2026 481Views 0Likes

Knightscope, Inc. (NASDAQ: KSCP) is making a broader case than “robots on patrol.” With record second-quarter revenue, an expanding national client base, new AI-driven security capabilities and an integrated model that joins autonomous machines with trained human professionals, the company is positioning itself…

Promotional graphic for Tribe Public’s Eupraxia Pharmaceuticals webinar, “Food Shouldn’t Hurt: Why Eupraxia Pharmaceuticals Is Building a More Precise EoE Investment Story,” featuring CEO James Helliwell, MD; EoE inflammation imagery, precision-healing graphics and event details for Friday, August 21, 2026.

Food Shouldn’t Hurt: Why Eupraxia Pharmaceuticals Is Building a More Precise EoE Investment Story -( $EPRX $MRNA $MRK $REGN $SNY $TAK $XBI )

by John F. Heerdink, Jr. August 21, 2026 375Views 0Likes

Tribe Public CEO Presentation & Q&A: Hosted Friday, August 21 Tribe Public hosted its CEO Presentation and Q&A webinar, “Food Shouldn’t Hurt: EOE, Eupraxia, and a Promising New Treatment Approach,” featuring James Helliwell, MD, Chief Executive Officer of Eupraxia Pharmaceuticals Inc. (NASDAQ:…

Seven Boson’s Google Cloud Alliance and Sovereign AI Vision Point to the Next Enterprise Opportunity -( $GOOG $GOOGL )

by John F. Heerdink, Jr. August 20, 2026 363Views 0Likes

Seven Boson Group’s expansion within the Google Cloud partner ecosystem and its increasingly defined sovereign-AI strategy offer a bullish picture of a company aiming to participate in a more mature phase of the artificial-intelligence buildout. The premise is compelling: as AI moves…

Tag: Tribe Public

Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )

Serina Therapeutics Puts Advanced Parkinson’s Disease in the Spotlight – Thursday, September 24

Wall Street’s Bullish New Menu: Insider Conviction, OLED Speed, Virtual Care and a Parkinson’s Catalyst -( $AMWL $GME $LPL $PFE $SER $XBI )

Serina Therapeutics Brings a Fresh Dose of Momentum to Advanced Parkinson’s Care -( $SER $PFE $XBI )

The New Premium Asset: Attention That Shows Up

Knightscope’s Next Act: Why an Autonomous Security Force Could Turn a Fragmented Industry Into a Recurring-Revenue Opportunity -( $F $KSCP $LKQ $PLTR )

Alpha Cognition’s Commercial Alzheimer’s Story Is Getting Harder to Ignore -( $ACOG )

Knightscope (NASDAQ: $KSCP) to Spotlight Autonomous Security Force Built With AI, Robotics and Humans at Tribe Public CEO Webinar – Sept. 10

Food Shouldn’t Hurt: Why Eupraxia Pharmaceuticals Is Building a More Precise EoE Investment Story -( $EPRX $MRNA $MRK $REGN $SNY $TAK $XBI )

Seven Boson’s Google Cloud Alliance and Sovereign AI Vision Point to the Next Enterprise Opportunity -( $GOOG $GOOGL )

Your Guide To Staying Informed In The Markets